Carotid Artery Stenosis Market: Introduction
- Carotid stenosis, also known as carotid artery disease, is characterized by the narrowing of the carotid arteries, the primary blood vessels that carry oxygenated blood to the brain. The narrowing is caused by plaque or fatty deposits along the inner wall of the artery, resulting in reduced blood flow to the brain.
- Over time, plaque deposits inside the inner wall of the artery can form a large mass that narrows the lumen, the inside diameter of the artery, and cause a complete blockage of the artery
- Atherosclerotic plaque in the cervical carotid artery is the most common cause of carotid stenosis. Stenosis can worsen over time to completely block the carotid artery, which could lead to stroke, a medical emergency that occurs when the blood supply to the brain is interrupted or reduced significantly.
Key Drivers, Restrains, and Opportunities of Global Carotid Artery Stenosis Market
- High prevalence of carotid artery stenosis among the geriatric population, rise in prevalence of diabetes, and surge in tobacco consumption are projected to drive the global carotid artery stenosis market during the forecast period
- According to the WHO, stroke accounts for 17 million deaths across the globe each year. Over 500,000 new cases of stroke are reported in the U.S. each year, and carotid stenosis is estimated to cause 20% to 30% of these. Hence, demand for early diagnosis and treatment to prevent death from stroke is high.
- Increase in patient awareness about early detection, prevention, and treatment of heart attacks and stroke are also expected to boost the growth of the global carotid artery stenosis market
- However, high cost of treatment and strict government regulations required for the approval of new and advanced technological devices and drugs are likely to restrain the global market in the near future
North America to Capture Major Share of Global Carotid Artery Stenosis Market
- North America is projected to account for major share of the global carotid artery stenosis market due to technological advancements, extensive R&D, and rise in awareness about the treatment and management of chronic diseases
- The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. Launch of new products, favorable regulations, high number of stroke patients, and rise in awareness are expected to drive the market in the region during the forecast period.
Key Players Operating in Global Carotid Artery Stenosis Market
The global carotid artery stenosis market is highly consolidated due to the presence of small number of key players. These players hold market major share in their respective regions. Growth strategies adopted by leading players are likely to drive the global carotid artery stenosis market.
Major players operating in the global carotid artery stenosis market are listed below:
- AstraZeneca plc
- Bristol-Myers Squibb
- advanceCor GmbH
- Pfizer, Inc.
- Merck & Co, Inc.
- Medtronic plc
- GE Healthcare
- Eli Lilly and Company
- Teleflex, Inc.
- Cardinal Health
- Daiichi Sankyo Co. Ltd.
- Abbott Laboratories
- Siemens Healthcare
- Other prominent players
Global Carotid Artery Stenosis Market: Research Scope
Global Carotid Artery Stenosis Market, by Type
- Diagnosis
- Magnetic Resonance Imaging (MRI)
- Computed Tomography Scan (CT Scan)
- Carotid duplex ultrasound
- Others
- Treatment
- Medication
- Antiplatelet
- Cholesterol-Lowering Statins
- Antihypertensive
- Other
- Surgery
- Carotid Endarterectomy
- Carotid Artery Angioplasty
- Carotid Artery Bypass
Global Carotid Artery Stenosis Market, by End-user
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Carotid Artery Stenosis Market, by Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
